ArticleMolecular neurobiology2025
Deep Hypothermic Low Flow Results in Multiple Aspects of Neurological Deficits in Mice by eEF2 Hyperphosphorylation.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Human umbilical cord blood mononuclear cells ameliorate vascular dementia by modulating microglial myelin debris handling and white matter injury.Journal of neuroinflammation · 2026Article
- Betulinaldehyde Ameliorates Aβ-Induced Neurotoxicity and Cognitive Deficits by Modulating the eEF2K/eEF2 Pathway.CNS neuroscience & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Postoperative neurological dysfunction is a common complication caused by deep hypothermia with cerebral hypoperfusion during aortic arch surgery, but the exact pathological changes and molecular mechanisms are not yet clear. In this study, we established an adult mouse model of deep hypothermic low flow (DHLF) to simulate the ischemic-reperfusion brain injury during aortic arch surgery. The DHLF-modeled mice showed significant neurological and cognitive dysfunction, accompanied by reduced dendritic spine density and increased glial cell activation in the hippocampus and cortex. DHLF induced proteomic changes primarily involved in synaptic organization in the hippocampus and cortex, with AMPA and NMDA receptor subunits and synaptic activity-dependent proteins markedly downregulated in the hippocampus and/or cortex. Moreover, DHLF also resulted in altered proteome in mRNA translation and inhibition of eukaryotic elongation factor 2 (eEF2), a crucial regulator of translational elongation whose activity is negatively regulated via phosphorylation by eEF2 kinase (eEF2K). Importantly, the administration of the small-molecular eEF2K inhibitor A484954 ameliorated DHLF-induced neurobehavioral dysfunction, dendritic spine reduction, and glial cell activation, suggesting that eEF2K/eEF2 may be a promising therapeutic target in DHLF-induced neurological injury. Our findings revealed new evidence of pathological features, molecular mechanism, and intervention of DHLF-induced cerebral ischemia-reperfusion injury, providing promising insight for developing strategies on reducing postoperative neurological complications after aortic arch surgery.
Indexed as
Identifiers
40014267What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.